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ABSTRACT
Stem cell identity and plasticity are controlled by
master regulatory genes and complex circuits also
involving non-coding RNAs. Circular RNAs (circR-
NAs) are a class of RNAs generated from protein-
coding genes by backsplicing, resulting in stable
RNA structures devoid of free 5’ and 3’ ends. Lit-
tle is known of the mechanisms of action of circR-
NAs, let alone in stem cell biology. In this study,
for the first time, we determined that a circRNA con-
trols mesenchymal stem cell (MSC) identity and dif-
ferentiation. High-throughput MSC expression profil-
ing from different tissues revealed a large number of
expressed circRNAs. Among those, circFOXP1 was
enriched in MSCs compared to differentiated meso-
dermal derivatives. Silencing of circFOXP1 dramati-
cally impaired MSC differentiation in culture and in
vivo. Furthermore, we demonstrated a direct inter-
action between circFOXP1 and miR-17–3p/miR-127–
5p, which results in the modulation of non-canonical
Wnt and EGFR pathways. Finally, we addressed the
interplay between canonical and non-canonical Wnt
pathways. Reprogramming to pluripotency of MSCs
reduced circFOXP1 and non-canonical Wnt, whereas
canonical Wnt was boosted. The opposing effect was
observed during generation of MSCs from human
pluripotent stem cells. Our results provide unprece-
dented evidence for a regulatory role for circFOXP1
as a gatekeeper of pivotal stem cell molecular net-
works.
INTRODUCTION
Human mesenchymal stem cells (MSCs) are multipotent
cells that can be isolated from various adult or perinatal
tissues and possess the ability to self-renew in culture and
differentiate into mesodermal derivatives, including osteo-
cytes, chondrocytes and adipocytes (1–3). Due to this dif-
ferentiation potential and other properties to regenerate
injured tissues indirectly via growth factor secretion and
immunomodulation, MSCs hold promise for regenerative
medicine. In particular, MSCs are used in bone reconstruc-
tion therapies and are frequently associated with biomate-
rials or subjected to ex vivo stimuli to induce proper mat-
uration into fully functional osteocytes and chondrocytes
(4). The therapeutic efficacy of MSCs hinges upon a fine
control of MSC lineage specification. Thus, it is crucial to
gain a deeper understanding of the molecular mechanisms
that regulate their differentiation (5–7). Factors involved in
fate decision and intermediate or final stages ofMSC differ-
entiation, such as Wnt and transforming growth factor-,
have attracted increasing attention from the scientific com-
munity (8–10). On the other hand, little is known about
the molecular mechanisms that regulate the maintenance
of humanMSC identity and their uncommitted state. Even
though roles for epidermal growth factor receptor (EGFR)
and non-canonical Wnt signaling have been documented
(11–13), the integration of these signaling pathways with
epigenetic regulators, such as non-codingRNAs (ncRNAs),
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is not understood. Therefore, the aim of this study was to
uncover molecular networks that sustain the undifferenti-
ated state and self-renewal of MSCs in an epigenetic per-
spective.
Mammalian cells contain thousands of RNA molecules
that do not code for proteins, but play key roles in the regu-
lation of physiological processes (14–16). Recent research
has indicated that microRNAs (miRNAs) and long non-
coding RNAs (lncRNAs) regulate the differentiation and
cell fate decisions of MSCs (17–19). Circular RNAs (circR-
NAs) are a recently discovered class of ncRNAs. Although
the existence of circRNAs was proposedmore than 20 years
ago, for many years they were thought to be functionless
byproducts of mRNA splicing (20–22). Nevertheless, recent
studies have identified a large number of endogenous circR-
NAs in various tissues, at different developmental stages,
and in many organisms under diverse conditions of growth
and stress, thus hinting at a relevant functional role of cir-
cRNAs in cellular biology and pathophysiology (23–25).
CircRNAs may be generated from exons, introns or
intron-containing exons by a back-splicing reaction that co-
valently links an upstream 3′-splice site to a downstream 5′-
splice site, leading to a closed loop structure (26). This par-
ticular conformation is reported to increase the stability of
circRNA, compared to its linear counterpart. Even though
the mechanisms underlying these events are not fully un-
derstood, recent studies have demonstrated that the pres-
ence of specific mammalian genomic features, such as re-
verse complementary sequences in the flanking introns and
the activity of specific RNA-binding proteins, enhance cir-
cRNA biogenesis (27–30).
Concerning the biological function of circRNAs, their
mechanisms of action have been largely unexplored. It
has been proposed that some circRNAs play an impor-
tant role in gene regulation by acting as competing endoge-
nous RNAs (ceRNAs). For instance, miRNA ‘sponging’ is
a mechanism of action of ceRNA, as shown for SRY and
CDR1 as in neuronal tissues (24,31) and for HIPK3 in var-
ious cancers (32). In addition, circRNAs can promote the
expression of their parental genes by regulating the RNA
Pol II transcription complex in the nucleus (33).
Other mechanisms for circRNAs have been proposed,
e.g. as hubs for protein interaction, as shown for circ-Mbl,
which interacts with the Mbl protein to compete for the
splicing of its linear counterpart (29). Furthermore, circ-
Foxo3 has been demonstrated to regulate cell cycle progres-
sion by forming ternary complexes with CDK2 and p21
(34). Moreover, it has recently been shown that circRNAs
can be translated efficiently into small truncated peptides,
even though the molecular activity of this type of circRNA-
derived protein is not yet understood (35). Finally, high con-
servation of circRNAs across species and their tissue- and
developmental stage-specific expression suggest their role
in cell identity and fate determination during development
(23,24,36–39).
In the current study, we report the unique role of a cir-
cRNA originating from the FOXP1 gene (circFOXP1) in
the maintenance of MSC identity and regulation of differ-
entiation. CircFOXP1 acts as a miRNA sponge targeting
miR-17–3p and miR-127–5p, and promotes proliferation
and differentiation of MSCs, supporting the hypothesis of
circRNAs asmajor players in stem cell fate decision-making
processes.
MATERIALS AND METHODS
Cell line, cell culture and treatments
MSCs and HSFs were cultured in -minimum essential
medium supplemented with 20% fetal bovine serum (FBS;
Life Technologies, cat. no. 10270–106) at 37◦C and 5%CO2.
MSCs were isolated from both cord blood and bone mar-
row, as described previously (40–43). TheMSC identity was
confirmed by the immunophenotype profile (1): cells were
positive for the MSC surface antigens CD73, CD90 and
CD105, and were negative for the hematopoietic markers
CD45 and CD34 (data not shown). The human material
was obtained after informed consent from healthy donors,
and the study was approved by the internal Ethics Com-
mittee. All experiments were performed according to the
amended Declaration of Helsinki.
Adipo-, osteo- and chondrogenic differentiation of
MSCs was induced using hMSC Osteogenic Bullet Kit
(Lonza, cat. no. PT-3002), hMSC Chondro Bullet Kit
(Lonza, cat. no. PT-3003) and hMSCAdipogenic Bullet Kit
(Lonza, cat. no. PT-3004) according to the manufacturer’s
instructions. Differentiationwas confirmed by staining with
Oil Red O (SigmaAldrich, cat. no. O1391) for adipogenesis,
Alizarin Red (Sigma Aldrich, cat. no. 130–22-3) for osteo-
genesis and Alcian Blue (Sigma Aldrich, cat. no. A5268) for
chondrogenesis.
HEK-293T cells were obtained from the American Type
CultureCollection (ATCC) andwere cultured inDulbecco’s
modified Eagle medium supplemented with 10% FBS. All
cells were routinely tested for mycoplasma using the My-
coAlert Mycoplasma Detection kit (Lonza, cat. no. LT07).
Human induced pluripotent stem cells (hiPSCs) derived
from MSCs were generated and characterized by uSTEM
company (uSTEM, Padova, Italy). uSTEM also generated
BJ fibroblasts-hiPSCs used to obtain hiPSC-derivedMSCs,
following the protocol described elsewhere (44).
Transcription was blocked by adding 1 g/ml actino-
mycin D (Sigma Aldrich, cat. no. A9415) or dimethyl
sulphoxide (Sigma Aldrich, cat. no 472301) as a control to
the cell culture medium.
Microarray analysis
Sample preparation and microarray hybridization were
performed according to the manufacturer’s protocol (Ar-
raystar). Briefly, circRNAs were treated with Rnase R to
remove linear RNAs. Then, each sample was amplified and
transcribed into fluorescent cRNA using the random prim-
ing method with a Super RNA Labeling Kit (Arraystar).
The labeled cRNA was hybridized onto an Arraystar Hu-
man Circular RNA Microarray (Arraystar V1.0). The ar-
ray was scanned with the Agilent Scanner G2505C, and raw
data were extracted by Agilent Feature Extraction software
(version 11.0.1.1). Identification of circRNAs followed cir-
cBASE database nomenclature (45).
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RNA isolation, reverse transcription and qRT-PCR analysis
The total RNA from cell lines was isolated using TRI-
zol reagent (Ambion, cat. no. 15596–026). For RNA isola-
tion from adipo, osteo and cartilage healthy tissues, sam-
ples were disrupted using Tissue Tearor (Biospec Prod-
ucts). RNA concentration and quality were verified using a
NanoDropND-1000 spectrophotometer (NanoDropTech-
nologies).
For the quantitative real time PCR (qRT-PCR) assay,
cDNAwas synthesized from 1g of total RNAwith Super-
Script IV VILO (Invitrogen, cat. no. 11756500). The cDNA
was diluted 10-fold and 1 l used as template for qRT-
PCR analysis using SYBRSelectMasterMix for CFX (Life
Technologies, cat. no. 4472937) on a CFX96 thermal cycler
(BioRad) following themanufacturer’s instruction. Accord-
ing to the MIQE guidelines (46), amplification efficiency,
correlation coefficient and slope of standard curves gener-
ated using serial dilutions for each primer pair were evalu-
ated (Supplementary Table S1). The relative expression lev-
els of the selected targets were determined using the Ct
method and normalized, where not differentially specified,
toACTBmRNA levels. In the case of miRNA, the miScript
II RT Kit (Qiagen, cat. no. 218161) and miScript SYBR
Green PCRKit (Qiagen, cat. no. 218073) were used, accord-
ing to the manufacturer’s protocols.
qRT-PCR products were resolved on 2% agarose gel.
The DNA products were gel purified using the Wizard SV
Clean-Up system (Promega, cat. no. A9281), according to
the manufacturer’s protocol, and submitted to Sanger se-
quencing for sequence validation. All primers used in this
study, listed in Supplementary Table S2, were designed us-
ing Primer 3 software.
DNA construct and mutagenesis
To obtain the expression of circFOXP1, the genomic re-
gion with the Alu sequence was amplified using Q5 High-
Fidelity DNA Polymerase (NEB, cat. no. M0491). The
polymerase chain reaction (PCR) products were inserted
into the pEYFP-C1 vector. The luciferase reporter was
constructed by subcloning the circFOXP1 fragment di-
rectly downstream of the Renilla luciferase cassette into
the psiCHECK2 vector. Mutation of each miRNA-binding
site was performed using the Q5 Site-Directed Mutagenesis
Kit (NEB, cat. no. E0554S). For the CRISPR/Cas9 assay,
gRNA cloning vectors were constructed using pUC-gRNA
cloning vector. All constructs were verified by sequencing.
All primers used are listed in Supplementary Table S2.
RNase R treatment of total RNA
A 2 g sample of total RNA was treated with 3 U/g of
Rnase R (Epicentre Biotechnologies, cat. no. RNR07250)
or water as a control (Mock) for 20 min at 37◦C. Digested
RNAwas subsequently purified using anRNeasyMinElute
Cleanup Kit (Qiagen, cat. no. 74204).
Nuclear and cytoplasmic fractionation
Nuclear/cytoplasmic fractionation was performed as fol-
lows. Cells werewashedwith cold phosphate-buffered saline
(PBS), harvested by scraping and centrifuged for 5 min at
500× g. Cell pellets were lysed in 5× (v/v) ice-cold Buffer A
(10mMTris–HCl, pH7.4, 10mMNaCl, 3mMMgCl2, 10%
glycerol, 1 mM ethylenediaminetetraacetic acid (EDTA),
0.5 mM dithiothreitol (DDT) and protease inhibitor cock-
tail) for 10 min at 4◦C. Lysates were cleared by centrifuga-
tion for 5 min at 1200× g and 4◦C, and the supernatant was
collected and saved as the cytoplasmic fraction on ice. The
crude nuclear pellet was resuspended in 250 l of Buffer B
(10 mM Tris–HCl, pH 7.5, 15 mMKCl, 30 mMNaCl, 10%
glycerol, 1 mM EDTA, 0.3% sodium deoxycholate, 0.5%
IGEPAL, 0.5 mM DTT, and 1× protease inhibitor cock-
tail) and centrifuged for 5min at 1200× g and 4◦C. The pel-
let was resuspended in 5 × (v/v) ice-cold Buffer F (10 mM
Tris–HCl, pH 7.0, 100 mM NaCl, 30 mM Na Pyrophos-
phate (Na4P2O7), 50 mMNaF, 5 mM ZnCl2, 1% Triton X-
100 and 1× protease inhibitor cocktail), incubated for 10
min on ice and then centrifuged for 5 min at 12 000× g and
4◦C. The nuclear supernatant was collected on ice.
RNA FISH
In situ hybridization was performed using biotinylated
DNA oligonucleotides (probes) specific for the circ-
FOXP1 sequence or negative control (Supplementary
Table S2). MSCs at 80–90% confluence were fixed in
4% paraformaldehyde for 20 min. After prehybridization
(PBS/0.5% Triton X-100), cells were incubated with probes
in hybridization buffer (40% formamide, 10% dextran sul-
fate, 4× saline-sodium citrate buffer, 10 mM DDT and
1 mg/ml yeast transfer RNA) at 37◦C overnight. Signals
were detected using a tyramide-conjugated Alexa 568 flu-
orochrome tyramide signal amplification kit (Invitrogen,
cat. no. T20934). Nuclei were counterstained with 4′,6-
diamidino-2-phenylindole (Invitrogen, cat. no. D1306). Im-
ages were acquired using a Leica TCS SP2 confocal micro-
scope, with an HCX PL APO IBD.BL 63 × /1.4 objective.
Oligonucleotide transfection
A predesigned siRNA targeting human circ FOXP1 (si-
circ FOXP1) and negative control (scrambled siRNA, siS-
CRL) were purchased from Integrated DNA Technologies.
The sequences used are listed in Supplementary Table S2.
MSCs were transfected with siRNA at a final concentration
of 10 nMusing Lipofectamine RNAiMAX (Invitrogen, cat.
no. 13778030), according to the manufacturer’s protocol.
Cells were grown for 48 h post-transfection and harvested.
Cell proliferation assay
Transfected MSCs were seeded onto 24-well plates in cul-
ture medium containing serum and maintained for 2 days
at 37◦C. The cells were harvested, and the cell number was
determined using a Coulter counter, as described previously
(47).
Luciferase reporter assay
At 24 h prior to transfection, HEK-293T cells were seeded
in 24-well plates at a density of 1 × 105. The cells were co-
transfected with 0.5 g of reporter vectors and 15 pmol
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of miRNA mimic. After 48 h, the luciferase activity was
measured with the dual-luciferase reporter assay system
(Promega, cat. no. E1910). For each assay, one internal con-
trol (Firefly Luciferase reporter, FLuc) and one negative
control (miRNA negative control) were used. To take into
account the transfection efficiency variability, the RLuc ac-
tivity was first normalized to the FLuc activity. The fold
change was determined by comparing the activity of each
miRNA mimic with that of the miRNA negative control.
RNA pull-down assay
The RNA pull-down experiment was performed in at least
three independent biological samples, as described previ-
ously (34,48), with minor modifications. Briefly, 1 × 107
HEK-293T cells were cross-linked with ultraviolet light at
4000 mJ/cm2 in ice-cold PBS and then pelleted at 1300
× g for 5 min. The pellet was resuspended in ice-cold Ly-
sis Buffer (50 mM Tris–HCl, pH 7.5, 100 mM NaCl, 1%
IGEPAL, 1 mM DDT, 0.1 U/l RNasin (Promega, cat.
no. N2111) and protease inhibitor cocktail). The cell lysates
were incubated overnight at 37◦C with 3 g of biotinylated
DNA oligonucleotides (probes), specific for the circFOXP1
sequence or negative control in two volumes of Hybridiza-
tion Buffer (50 mM Tris–HCl, pH 7.5, 700 mM NaCl, 6
mMEDTA, 1% IGEPAL, 15% formamide, 1mMDDT, 0.1
U/l RNasin and protease inhibitor cocktail). A total of 50
l of washed Streptavidin C1 magnetic beads (Invitrogen,
cat. no. 65001) were blocked for 1 h at room temperature
with 0.5mg/ml yeast total RNA and 1mg/ml bovine serum
albumin. Subsequently, blocked beads were added to each
binding reaction and incubated for 2 h at 37◦C. The beads
were sequentially washed five times with Wash Buffer (2×
saline-sodium citrate buffer, 0.5% IGEPAL, 1 mM phenyl-
methylsulphonyl fluoride and 0.1 mMDDT). After treating
with DNase, RNAs were extracted by an miRNeasy Mini
Kit (Qiagen, cat. no. 217004) and analyzed by quantitative
real-time PCR.
Surgical, cell injection and follow-up procedures
Wistar albino male rats (Rattus norvegicus) were supplied
by Envigo® and allowed to acclimatize for at least 7 days
before the start of surgical procedures, which were all ap-
proved by the UK Home Office and Local Research Ethics
Committee. All procedures were performed under sterile
conditions. Isoflurane inhalation was used for induction
(5%) and maintenance (2.5–3%) of anesthesia. To avoid hy-
pothermia during procedure, a heat pad was placed un-
der the surgical surface, and subcutaneous pre-medications
were given as follows: Buprenorphine 0.05 mg/kg, Ibupro-
fen 4 mg/kg, Synulox® antibiotic 0.5 ml and 5cc warm
normal saline. Skin was prepared using chlorhexidine and
the leg was draped. A longitudinal skin incision over the
antero-medial side of the leg was made, followed by dissec-
tion of subcutaneous tissue and exposure of the tibia. Sur-
rounding muscles and soft tissue were carefully detached
from around the bone. Under 0.9% saline irrigation, a
fracture/osteotomy was created in the mid-shaft using a ro-
tatory burr and a 1-mm gap created and maintained with a
stainless steel spacer. Stripping of the periosteum and en-
dosteum was performed to a distance equal to one bone
diameter of the diaphysis proximally and distally using a
periosteal stripper externally and the bent end of a needle
(23G) internally. A needle was introduced retrogradely from
the fracture site toward the tibial tuberosity. This needle
was used as guide for second needle introduced in an an-
tegrade direction. Once the latter reached the fracture site,
the spacer was inserted and the needle was then passed into
the distal medullary canal and fixed into the distal frag-
ment. The skin was sutured using an absorbable monofila-
mentMonocryle 4/0. Another dose of Buprenorphine (0.05
mg/kg) was given after 24 h to control post-operative pain.
Three weeks after this procedure to create the
fracture/osteotomy, cultured cells were trypsinized,
processed and resuspended in 150 l PBS, a 26G needle
and 1 ml syringe were used to deliver the cells in vivo. Cells
were injected into the fracture site using the novel Z-track
technique to prevent backflow leakage and to avoid cell loss
after injection. Rats were randomized into two groups and
injected as follows: 4 × 105 circFOXP1-KD BM-MSCs
were injected into the experimental group (n = 6) and
similar number of scramble knockdown BM-MSCs was
injected into the control group (n = 6).
Animals were closely monitored and no local or systemic
side effects were noticed post-injection. Animals were X-
rayed weekly for 8 weeks to follow the progression of the
healing process.
Mechanical analysis was performed in 4-point bending
using a mechanical testing machine (Zwick/Roell). A load
(12.5N) was applied, producing a bending moment at the
fracture site of 0.05 Nm, which was considered to represent
the bending moment that would occur on the tibia during
normal walking. Intact legs were used as controls for each
subject.
Computational and statistical analysis
Raw data of profiled circRNAs were normalized by the
quantile method, as implemented by GeneSpring GX
v11.5.1 software (Agilent Technologies). Differential ex-
pression determination of circRNA binding with multiple
miRNAs, the details of the miRNA response elements and
the initial miRNA target prediction were performed with
proprietary algorithms at Arraystar, then further processed
as detailed below.
The batch effect on raw data was taken into account
and smoothened using the ComBat method (49). Sample
distances were assessed on normalized data with principal
component analysis calculated by the ‘prcomp’ function in
base-R. Selection of differentially expressed features (circR-
NAs) was performed using fold change and unpaired t-tests
with cutoffs on unadjusted P-values.
Selected miRNAs were used as inputs to build the inter-
action network to find genes for the pathway analysis with
the CyTargetLinker plugin (using the availablemiRTarbase,
TargetScan and microCosm modules) in Cytoscape version
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3.1.0. Pathway enrichment analyses of the resulting gene
lists were performed in Cytoscape using the ClueGO plu-
gin screening GO terms, Reactome and KEGG databases;
exported results were further processed and displayed with
R.
All statistical tests were performed using Prism 7 (Graph-
Pad). Statistical parameters are reported in figure legends
and include: number of replicates analyzed (n), dispersion
and precision measures (mean ± standard deviations or
standard error of the mean) and statistical significance (P-
value). All data were normally distributed according to the
Shapiro–Wilk normality test and then statistically assessed
by two-tailed Student’s t-test or one-way ANOVA test fol-
lowed by Dunnett’s multiple comparisons post-hoc test as
indicated in figure legends. In figures, asterisks mean *P <
0.05, **P< 0.01, ***P< 0.001, ns = not significant. P val-
ues <0.05 and lower were considered significant. All exper-
iments were performed in triplicate biological replicates.
RESULTS
MSCs possess a unique circRNA expression profile compared
to differentiated fibroblasts
To determine which circRNAs may play a role in MSC def-
inition and fate decision, a high-throughput screening as-
say was first performed. Primary MSCs isolated from both
human bone marrow (adult stem cell source; BM-MSCs,
n = 3) and umbilical cord blood (perinatal/fetal stem cell
source; CB-MSCs, n= 3) were used to exclude tissue source-
related molecular biases. Moreover, human skin fibroblasts
(differentiated stromal cell counterpart; HSFs, n = 3) were
also analyzed to rule out circRNAs associated with generic
stromal identity and the differentiated state (Supplementary
Table S3).
First, circRNAs were identified by microarray analysis
of total RNA. Interestingly, an integrated principal com-
ponent analysis (PCA) showed that the three cell popu-
lations cluster independently (Figure 1A), suggesting ho-
mogeneous and well-defined, tissue-specific circRNA ex-
pression profiles. Considering that BM-MSCs represent the
gold standard in theMSC research field and that HSFs rep-
resent the differentiated stromal population, differentially
expressed circRNAs between BM-MSCs andHSFswere se-
lected for a clustering analysis along with CB-MSCs, apply-
ing a fold-change filter based on P-values ≤ 0.05. Intrigu-
ingly, unsupervised hierarchical clustering showed that CB-
MSCs cluster together with BM-MSCs, while both of them
were distant from HSFs (Figure 1B). Among the selected
circRNAs, 93 showed differential expression, with a fold
change ≥ 1.5. In detail, 32 were upregulated, whereas 61
were downregulated in MSCs compared to HSFs (Figure
1C).
Subsequently, a subset of top differentially expressed cir-
cRNAs (n= 10 upregulated and n= 3 downregulated) were
selected for further validation with independent biological
replicates. CircRNA expression levels were quantified by
qRT-PCR with divergent primers to distinguish circRNAs
from linear counterparts. Those that were consistent with
the microarray data are shown in Figure 1D. Finally, the
presence of head-to-tail junction sequences was confirmed
by Sanger sequencing for differentially expressed circRNAs
(Supplementary Figure S1).
CircFOXP1 is a marker of undifferentiated MSCs
To address whether differentially expressed circRNAs ac-
tively participate in theMSC regulatorymolecular network,
expression changes of validated top-upregulated MSC cir-
cRNAs were examined during lineage specification. Well-
established cell culture models for in vitro differentia-
tion into mesodermal derivatives (osteo-, chondro- and
adipocytes) were implemented, involving specific staining
protocols and molecular analyses (Figure 2A and B; Sup-
plementary Figure S2A). qRT-PCR analysis showed that
hsa circ 0001320, a circRNA originating from the FOXP1
gene (termed as circFOXP1), was the strongest regulated
circRNA among the validated top-upregulated circRNAs
in all differentiated mesodermal cell types (Figure 2C and
Supplementary Figure S2B). Importantly, these data were
confirmed in primary human tissues (Figure 2D). In ad-
dition, time-course analysis revealed that circFOXP1 was
downregulated shortly following the first days of differen-
tiation (Figure 2E), suggesting that its expression is strictly
related to the undifferentiated MSC state. Intriguingly, cir-
cFOXP1 showed the same trend of its linear counterpart
(Supplementary Figure S2C), which may hint at a cor-
relation between circFOXP1 and FOXP1 mRNA tran-
scriptional levels, as already reported for other circRNAs
and their linear counterparts (50,51). To corroborate these
data, we also analyzed circFOXP1 expression in MSCs iso-
lated from other sources (Wharton’s jelly and adipose tis-
sue, as additional perinatal/fetal and adult sources, respec-
tively), and the same expression levels were observed within
each group (Figure 2F). Finally, CB-MSCs and BM-MSCs,
along with HSFs, derived from male and female donors
showed that circFOXP1 expression is gender independent
(Figure 2G). Altogether, these data indicate that circFOXP1
is a specific molecular marker for undifferentiated MSCs.
CircFOXP1 is an exon-based RNase-resistant RNA that lo-
calizes to the cytoplasm
The genomic structure of circFOXP1 was obtained from
the UCSC genome database (http://genome.ucsc.edu/). Its
full genomic length is 38 225 bp, while its spliced length
is 692 bp, comprised of five exons with high conservation
across 100 species of vertebrates (Figure 3A). Subsequently,
the mechanism of circFOXP1 biogenesis was investigated.
It has been proposed that complementary Alu sequences in
an inverted orientation across long flanking introns can fa-
cilitate the formation of circular RNAs (27,52,53). Along
this hypothesis, the introns flanking circFOXP1 were an-
alyzed. Interestingly, two inverted short-interspersed ele-
ments, AluJr4 (18 267 bp downstream the 3’-end of circ-
FOXP1) and AluJr (5492 bp upstream the 5’-end of circ-
FOXP1), showing a highly reverse complementarity (71%
identity over 239 nt; Supplementary Figure S3A), were de-
tected. Thus, two 500-nt regions containing these Alu se-
quences were cloned into the pEYFP expression vector in
different combinations (Supplementary Figure S3B). Mod-
ulation of the circRNA transcriptional level was detected
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Figure 1. Mesenchymal stem cells (MSCs) possess a unique circularRNA (circRNA) expression profile compared to differentiated fibroblasts. (A) Principal
component analysis of the circRNA expression profiles of bone marrow MSCs (BM-MSCs), cord blood MSCs (CB-MSCs) and human skin fibroblasts
(HSFs). Each cell type was assayed in triplicate. (B) Heat map of the most differentially expressed circRNAs (cut-off was set to -1.5 > fold change >1.5)
between MSCs and HSFs, with columns representing circRNAs and rows representing samples. The circRNAs were classified according to the Pearson
correlation (Z-score). (C) A volcano plot was used to visualize differential circRNA expression between MSCs and HSFs. The red dots represent the
differentially expressed circRNAs with statistical significance (P< 0.01); downward arrows indicate downregulated circRNAs and upward arrows indicate
upregulated circRNAs. (D) The relative transcriptional level of the top 10 differentially expressed circRNAs was confirmed by qRT-PCR analysis of RNAs
extracted from independent biological replicates of BM-MSCs, CB-MSCs and HSFs. Data in panel (D) are shown as means ± standard deviation (n =
3), statistical analysis was performed by one-way analysis of variance followed by the Dunnett correction; *P < 0.05, **P < 0.01, ***P < 0.001.
by qRT-PCR analysis after transfection of human embry-
onic kidney (HEK)-293T cells with the generated expres-
sion vectors. According to previous analyses, the presence
of two inverted complementary elements in the expression
vector was essential for the formation of circFOXP1, while
circularization was not increased when one or both Alu se-
quences were missing (Figure 3B). To validate the role of
Alu sequences in the circularization in a more physiological
and refined setting, we deleted the repeated sequence using
CRISPR/Cas9 technology. Two gRNAs were designed to
target the external ends of the AluJr4 region (Supplemen-
tary Figure S3C), and they were co-transfected in HEK-
293T cells stably expressing Cas9. We confirmed the dele-
tion of AluJr4 sequence by PCR. As previously demon-
strated, the absence of Alu region inhibited the circulariza-
tion of circFOXP1 (Figure 3C).
Subsequently, total RNA was treated with RNase R to
analyze the stability of circFOXP1. Indeed, RNase R is able
to degrade linear RNAs, but not circRNAs, thanks to its ex-
onuclease activity. As expected, circFOXP1 showed higher
resistance to RNase R digestion, compared to the linear
mRNA control (Figure 3D). Moreover, the circFOXP1
transcript exhibited a half-life >24 h after treatment with
actinomycin D, while its linear counterpart showed a half-
life <4 h (Figure 3E). These analyses provided additional
support that circFOXP1 has a bona fide circRNA structure.
Finally, since recent reports have proposed that the func-
tion of circRNAs is associated with their subcellular com-
partmentalization; nuclear/cytoplasmic fractionation was
performed onMSC samples to determine circFOXP1 local-
ization. CircFOXP1 was enriched in the cytoplasmic frac-
tion, as shown by qRT-PCR analysis (Figure 3F). Circ-
FOXP1 localization was further addressed by fluorescence
in situ hybridization (FISH), which directly revealed and
confirmed a clear cytoplasmic localization (Supplementary
Figure 3D). Altogether, these results demonstrate that circ-
FOXP1 is an abundant and highly stable circRNA present
in the cytoplasm of MSCs.
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Figure 2. CircFOXP1 is a specific mesenchymal stem cell (MSC) marker. (A) Schematic representation of the experimental outline. MSCs were grown
for 3 days in the presence of serum. Starting from day 0, MSCs were induced to differentiate into osteocytes, chondrocytes and adipocytes. At different
time points, the MSCs were analyzed for Alizarin Red S, Alcian Blue and Oil Red O staining positivity and the gene expression profile, as indicated. (B)
Representative images taken after 21 days of differentiation. An image of MSCs at the start of differentiation is included; scale bar, 200 m. (C) qRT-
PCR for circFOXP1 in MSCs, osteocytes, chondrocytes and adipocytes at the end of MSC differentiation. (D) qRT-PCR for circFOXP1 in MSCs as
well as bone, cartilage and adipose tissue. (E) The relative transcriptional level of circFOXP1 as MSCs (day 0) differentiated into osteocytes (day 4) and
adipocytes (day 7) was measured by qRT-PCR. Transcriptional levels were normalized to those of MSCs and were represented in log2 scale. (F) qRT-PCR
for circFOXP1 in MSCs originating from other sources, including Wharton’s jelly (WJ-MSCs) and adipose tissue (AD-MSCs). (G) The transcriptional
level of circFOXP1 in bone marrowMSCs (BM-MSCs), cord blood MSCs (CB-MSCs) and human skin fibroblasts (HSFs) isolated from male and female
individuals was measured by qRT-PCR. The relative expression levels in panels (C-E) were normalized to TBP. Data in panel (G) are shown as means
± standard deviation (n = 3); statistical analysis was performed by the Wilcoxon–Mann–Whitney non-parametric test. Data in panels (C), (D) and (F)
are shown as means ± standard error of the mean (n = 3); statistical analysis was performed by one-way analysis of variance followed by the Dunnett
correction; ns, not significant; *P < 0.05, **P < 0.01.
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Figure 3. CircFOXP1 is an exon-based RNase-resistant RNA that localizes to the cytoplasm. (A) Schematic representation of the genomic regions of the
FOXP1 gene from which circFOXP1 is originated, showing flanking Alu repeats and other short interspersed nuclear elements. Red arrows indicate the
complementary Alu sequences (AluJr4 and AluJr). Black arrows represent divergent primers binding to the transcribed genomic region of circFOXP1.
Conservation across 100 vertebrate species of the circFOXP1 sequence is illustrated. (B) HEK-293T cells were transfected with the expression plasmids
(pEYFP-: control, AluJr4-circFOXP1, circ-FOXP1-AluJr and AluJr4-circFOXP1-AluJr), and at 48 h post-transfection, the amount of circFOXP1 was
measured by qRT-PCR and normalized to yellow fluorescent protein (YFP). (C) Normal PCR data for CRISPR/Cas9-mediated deletions of AluJr4 region
and qRT-PCR for the reduction of circFOXP1 expression. (D) qRT-PCR was used to measure the abundance of circFOXP1 and FOXP1 mRNA after
RNase R treatment. The amounts of circFOXP1 and FOXP1 mRNA were normalized to the amounts of the mock-treated samples. (E) qRT-PCR was
used to determine the abundance of circFOXP1 and FOXP1 mRNA in MSCs treated with actinomycin D at the indicated time points. (F) Cytoplasmic
and nuclear fractions of cellular RNA were analyzed for circFOXP1 expression by qRT-PCR and expressed as a percentage of the input. U6 and RPS14
mRNAwere used as reference RNAs for nuclear and cytoplasmic fractions, respectively. Data in panel (C) are shown as the means ± standard error of the
mean (n = 3), statistical analysis was performed by two-tailed Student’s t-test; *P < 0.05, ***P < 0.001.
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CircFOXP1 maintains MSC differentiation capacity in vitro
To investigate the biological role of circFOXP1 in MSCs, a
knockdown experiment was performed. A small interfering
RNA (siRNA) targeting the back-splice junction sequence
of circFOXP1 and a scrambled negative control siRNA se-
quence were designed (Supplementary Figure S4A). These
siRNAs were transfected into MSCs, and the effect of
siRNA-mediated knockdown of circFOXP1 was assessed
after 48 h. As expected, the treatment effectively silenced
the circular transcripts, whereas it did not affect the ex-
pression of linear mRNAs (Figure 4A). A subsequent cell
proliferation assay showed that the downregulation of cir-
cFOXP1 markedly reduced MSC growth (Supplementary
Figure S4B). In addition, the MTT assay also revealed that
the cell proliferation of silenced MSCs was reduced by 20%
after 48 h (Supplementary Figure S4C).
Next, mRNA levels of MSC cell surface markers were
measured to investigate whether circFOXP1 knockdown
had consequences on the molecular profile of undifferen-
tiated MSCs (54). qRT-PCR analysis revealed that MSC
marker CD164, PDPN, CD146 and GLI1 (44,54–56) ex-
pression levels were reduced after 7 days (Figure 4B).
In agreement with these findings, flow cytometry analy-
sis of CD73, CD90, CD105 and CD146 showed that the
CD90+/CD146+ and CD73+/CD105+ double-positive
populations were less abundant in si-circFOXP1 MSCs
than si-scrl MSCs (Supplementary Figure S4D).
To establish whether circFOXP1 is essential for the main-
tenance of undifferentiated MSCs in long-term culture, we
transduced MSCs with a lentivirus expressing small hair-
pin RNA (shRNA) for circFOXP1 to generate a stable
knockdown. As previously observed after siRNA treat-
ment, shRNA effectively silenced circFOXP1 transcripts
and did not affect the expression of FOXP1 mRNA (Fig-
ure 4C and Supplementary Figure S4E). Then, control and
circFOXP1 knockdown (circFOXP1-KD) MSCs were in-
duced to undergo osteogenic and adipogenic differentia-
tion and analyzed after 21 days. After osteogenic induc-
tion, circFOXP1-KD MSCs showed a significantly lower
matrixmineralization, as evidenced byAlizarinRed S stain-
ing comparedwith the negative control (Figure 4D). A simi-
lar analysis was conducted tomeasure the capacity ofMSCs
to differentiate into the adipocytic lineage after circFOXP1-
KD. Oil Red O-stained circFOXP1-KDMSCs showed low
accumulation of intracellular lipid droplets, compared to
the negative control (Figure 4E). Taken together, the afore-
mentioned results indicate that circFOXP1 acts as a regula-
tor of the transcriptional program sustaining mesenchymal
stem cell identity.
CircFOXP1 regulates bone repair by MSCs
To establish whether circFOXP1-KDMSCs lose mesenchy-
mal identity and properties in vivo, we established an at-
rophic non-union model in the rat femur (Figure 5A).
Three weeks after osteotomy, MSCs transduced with sh-
circFOXP1 or a control shRNA were injected into the gap.
Rats were monitored after cell injection every week for 10
weeks by X-ray to assess progression of the healing process.
In the group treated with circFOXP1-KD MSCs only two
out of six rats developed bone union, one of which was only
partial. By contrast, in the control group, full union was
achieved in five out of six animals (P-value > 0.05, Fisher’s
exact test) (Figure 5B).
Postmortem clinical examination of the tibiae that devel-
oped normal union in the control group showed normal
rigidity and were able to withstand a simulated weight bear-
ing test. In contrast, non-union bones in the circFOXP1-
KD group revealed obvious motion at the osteotomy site.
When the leg was held from one end, deflection of the shaft
due to gravity was observed. Therefore, these were not eli-
gible for mechanical testing.
3D images from micro-CT visualization were recon-
structed to give a detailed view at the osteotomy site. The
control group showed good callus formation and bone
bridges filling the gap (Figure 5C and Supplementary Fig-
ure S5A), whereas in the circFOXP1-KD group no bone
bridge was found at the osteotomy site and fracture line
was clearly detectable, with a minimal gap distance in ex-
cess of 100m (Figure 5D and Supplementary Figure S5B).
In a particular case, one of the samples in the circFOXP1-
KD group was initially considered to be a union, but only
marginal callus formation and bone bridges were later ob-
served. Consequently, healing was considered to be subop-
timal, also considering the gapwidth of 96.091m,whereas
successful unions all displayed gaps of >50 m (Supple-
mentary Figure S5C and Supplementary Table S4). Recon-
struction of micro-CT data into 3D images gave detailed
information about callus shape at the osteotomy site and
showed the presence or absence of bone bridges between
fracture ends, discriminating unions and non-union (Figure
5C and D).
Finally, histological examination showed normal union
with bone bridges connecting fracture ends in the control
groups, while the circFOXP1-KD group showed non-union
filledwith fibrous tissue and no bone bridges (Figure 5E and
F).
CircFOXP1 acts as a competing endogenous RNA interact-
ing with multiple miRNAs
Previous research has proposed that circFOXP1 may act as
a ceRNAby sequesteringmiRNAs present in the cytoplasm
to inhibit translation of their target mRNAs (27,32,57).
Considering the cytoplasmic localization of circFOXP1, it
is conceivable that it plays a role in MSCs as a ceRNA. To
screenmiRNAs ‘sponged’ by circFOXP1, Arraystar propri-
etary algorithms based on the public databases TargetScan
and miRanda were used and the highest ranking candi-
date miRNAs were selected. To validate whether the miR-
NAs selected could interact with circFOXP1, a luciferase
reporter assay was performed. The sequence of circFOXP1
was inserted immediately downstream of the Renilla lu-
ciferase reporter gene (RLuc+circFOXP1), and then each
candidate interacting miRNA was co-transfected with the
luciferase reporter into HEK-293T cells. MiR-17-3p, miR-
127-5p and miR-370-3p were able to reduce the Renilla lu-
ciferase reporter activity, compared to the negative con-
trol, while miR-558 was not able to interact with the cir-
cFOXP1 sequence (Figure 6A). Subsequently, at least one
miRNA-binding site defined by the Arraystar proprietary
algorithms was confirmed using the miRDB and CircInter-
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Figure 4. The biological role of circFOXP1 is to maintain mesenchymal stem cells (MSCs) in their undifferentiated state. (A) The knockdown efficiency
of circFOXP1 and FOXP1 mRNA for si-circFOXP1 was measured by qRT-PCR. Both the circRNA and linear mRNA levels in control scrambled siRNA
(si-control) were set at 1. The RNA levels in si-circFOXP1 cells are shown as a fold change with respect to the control. (B) The relative transcriptional levels
of the indicated genes were measured by qRT-PCR in MSCs transfected with si-control or si-circFOXP1. (C) The knockdown efficiency of circFOXP1
for shcircFOXP1 was measured by qRT-PCR. The circRNA level in control shRNA (shGFP) was set at 1. (D) Left, representative images of Alizarin
Red S staining of MSCs grown for 21 days in osteogenic induction medium after circFOXP1 knockdown. Right, quantification of Alizarin Red S staining
via dissolving the dye and subsequent absorbance measurement at 405 nm; scale bar, 200 m. (E) Left, representative images of Oil Red O staining of
MSCs grown for 14 days in adipogenic induction and maintenance medium after circFOXP1 knockdown. Right, quantification of Oil Red O staining via
dissolving the dye and subsequent absorbance measurement at 405 nm; scale bar, 100 m. Data in panels (A), (B) and (C) are shown as means ± standard
error of the mean (n = 3), statistical analysis was performed by two-tailed Student’s t-test; *P < 0.05, **P < 0.01, ***P<0.001.
actome databases (58,59) (Supplementary Figure S6A and
Supplementary Table S5). Then, each confirmed miRNA
target site in the circFOXP1 sequence was mutated, and
the Renilla luciferase assay was repeated. No significant ef-
fect on luciferase levels was observed, demonstrating the
specificity of the miRNA–circFOXP1 target site interac-
tion (Figure 6B). Next, using a pull-down assay with biotin-
labeled oligonucleotides complementary to the back-splice
junction of circFOXP1, the direct interaction betweenmiR-
127-5p/miR-17-3p/miR-370-3p and circFOXP1 in its na-
tive circular structure was validated. HEK-293T cells were
transfected with circFOXP1 and each miRNA, and the
cell lysates were subjected to the pull-down assay. Equal
amounts of circFOXP1 were observed in the cell lysates
mixed with the specific or control probes (Supplementary
Figure S6B). Consistent with the Renilla luciferase reporter
assay, the circRNAprobe pulled downmore than 5-fold cir-
cFOXP1, compared to the control probe (Supplementary
Figure S6C). Noticeably, pull-down with the circFOXP1-
specific probe, but not the control probe, yielded not only
circFOXP1 but also miR-17–3p, miR-127–5p and miR-
370–3p (Figure 6C). The presence of the head-to-tail junc-
tion sequence of circFOXP1 in the pull-down assay was
confirmed by Sanger sequencing after resolving on an
agarose gel (Supplementary Figure S6D).
To explore the molecular mechanisms whereby cir-
cFOXP1 supports MSC identity, a circRNA–miRNA–
mRNA regulatory molecular axis was delineated using the
Cytoscape tool. Among the miRNAs found to be sponged
by circFOXP1, only miR-17–3p and miR-127–5p demon-
strated a potentially relevant role in the regulation of differ-
ent molecular pathways (Supplementary Figure S6E). Re-
actome and Gene Ontology (GO) database analyses per-
formed on the target genes of miR-17–3p and miR-127–
5p indicated a significant correlation with EGFR and non-
canonical Wnt signaling (Figure 6D and Supplementary
Figure S6F), which are associated with MSC proliferation
and self-renewal (11–13). To validate the bioinformatics
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Figure 5. CircFOXP1 knockdown reduce bone repair properties ofMSCs. (A) Schematic representation of experiment. (B) Box-and-whisker plot indicated
measurements of bone fracture after MSC treatment. (C andD) Three sectional images and 3D reconstruction of micro-CT analysis after 8 week MSCs
injection. (E andF) Hematoxylin/Eosin staining showed fibrotic tissue (*), osteocyte cells (&) and osteoblast cells (#). Data in panel (B) are shown as
means ± standard deviation (n = 6); statistical analysis was performed by two-tailed Student’s t-test; *P < 0.05.
analysis experimentally, we addressed the expression levels
of the direct target mRNAs ofmiR-17–3p andmiR-127–5p.
qRT-PCR analysis showed that WNT5A, ROR2, PIK3CA
and NRAS were downregulated upon circFOXP1 knock-
down (Supplementary Figure S6G).
We finally investigated whether the capacity of circ-
FOXP1 to maintain MSCs depends on miR-17–3p/miR-
127–5p inhibition. Synthetic mimics of these miRNAs
were transfected into MSCs. Next, miR-17–3p/miR-127–
5p overexpressing MSCs were induced to differentiate to-
ward the osteogenic lineage. Overexpression of miR-17–3p
and miR-127–5p inhibited osteogenic differentiation as in-
dicated by lower levels of Alizarin Red staining (Figure 6E).
Taken together, these results indicate that circFOXP1 acts
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Figure 6. CircFOXP1 acts as a competing endogenous RNA for multiple miRNAs. (A) Luciferase reporter assay for Renilla luciferase activity of RLuc-
circFOXP1 in HEK-293T cells co-transfected with miRNA mimics. (B) Luciferase reporter assay for Renilla luciferase activity of RLuc-circFOXP1 or
RLuc-circFOXP1 mutant in HEK-293T cells co-transfected with miRNA mimics. (C) Lysates prepared from HEK-293T cells co-transfected with circ-
FOXP1 and miRNA mimics were subjected to the RNA pull-down assay. The interaction of miR-17–3p, miR-127–5p and miR-370–3p with circFOXP1
was measured by qRT-PCR. (D) Reactome analysis of miRNA targets. The top 15 ranked Reactome pathways are shown. The y- and x-axis indicate
the enrichment factor (% of genes involved relative to the total number of pathway genes) and pathway name, respectively. The size of the dots indicates
the number of genes involved in the respective annotation category, while the color denotes the statistical significance of the enrichment. (E) Mineralized
nodule formation as assessed by Alizarin Red staining; scale bar, 200 m. Data in panels (A) and (B) are shown as means ± standard deviation (n = 3);
statistical analysis was performed by two-tailed Student’s t-test; **P < 0.01, ***P < 0.001.
as a regulator of MSC identity through inhibition of miR-
17-3p/miR-127-5p activity.
To address a broader role for circFOXP1 at the inter-
play between non-canonical and canonical Wnt pathways,
MSCs were reprogrammed to human-induced pluripotent
stem cells (hiPSCs), stably changing their stem cell iden-
tity. To maintain pluripotency, hiPSCs activate the canoni-
cal and disengage the non-canonical Wnt pathways, as re-
ported by the literature (60,61).Upon reprogramming (Sup-
plementary Figure S7A), circFOXP1 was downregulated
(Figure 7A). At the same time non-canonical Wnt5a lig-
and and Fzd1 co-receptor gene expression was silenced,
whereas canonical Wnt3a ligand, Lrp6 and Fzd7 recep-
tors mRNAs were upregulated (Figure 7A). Furthermore,
consistent with circFOXP1 deregulation, miR17-3p and
miR127-5p were upregulated (Supplementary Figure S7C).
To confirm these data, we also generated MSCs from hiP-
SCs (Supplementary Figure S7B) to address the oppo-
site process. In accordance with the previous results, cir-
cFOXP1 was upregulated in the newly generated hiPSC-
derived MSCs (Figure 7B). In detail, downregulation of
canonical Wnt3a, Lrp6 and Fzd7 was detected, whereas
non-canonical Wnt5a, Ror2 and Fzd1 were strongly upreg-
ulated (Figure 7B).
DISCUSSION
In the past couple of decades, the concept of a self-
reinforcing transcriptional regulatory network has driven
most of the pluripotent stem cell research (60,62). In par-
ticular, the stimuli necessary to exit this regulatory network
and enter differentiation have been investigated intensively
(63,64). Indeed, the current paradigm considers stem cells
in their undifferentiated state as poised to differentiate in
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response to transient signaling cascades, while still ensuring
the maintenance of cell identity through multiple rounds of
cell division. Controlling the equilibrium between stem cell
self-renewal and cell fate specification is indispensable for
maintaining tissue homeostasis. The deregulation of these
processes leads to loss of cell identity (65,66), an essen-
tial characteristic to be controlled for consistent regener-
ative medicine applications. Notwithstanding their impor-
tance, self-reinforcing regulatory networks and the molecu-
lar mechanism governing the transition of MSCs from the
undifferentiated state to mesodermal commitment are still
undefined, in particular with respect to ncRNAs.
In the past few years, ncRNAs have attracted much at-
tention as fundamental players in the regulation of molec-
ular networks related to differentiation pathways (67,68).
Among ncRNAs, circRNAs have emerged as novel regu-
lators of physiological cell functions (23,24,31,32). In this
work, for the first time, we determined the MSC circR-
NAome defined as the complete set of circRNAs detectable
in a given cell type. Compared with HSF, representative of
a terminally differentiated state, we found more downreg-
ulated than upregulated circRNAs in MSCs. This was in
accordance with previous works which showed that circR-
NAs were upregulated during differentiation (36,69), while
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a reduced number of circRNAs were found in proliferat-
ing compared to non-proliferating cells (70). These obser-
vations could be explained by circRNAs get passively di-
luted by cell proliferation or vice versa accumulated in non-
proliferating cells (terminally differentiated or quiescent)
due to their high stability. In our work, we well character-
ized and functionally defined the key role played by one
highly expressed circRNA in MSCs, hsa circ 0001320, de-
rived from the FOXP1 gene (termed as circFOXP1). Al-
though FOXP1 mRNA can produce more than 30 dif-
ferent circRNAs, as previously detected in other cell lines
(23,36,71), only circFOXP1 had consistently higher expres-
sion in MSCs. CircFOXP1 is composed of five exons and
is flanked on both sides by long introns containing many
Alu repeats. Previous studies have indicated that the pres-
ence of inverted repeats of Alu sequences (IRAlu) may fa-
cilitate RNA transcript circularization (23,24,27,36). Con-
sistent with this concept, our results also support the role
of RNA pairing by IRAlu in the enhanced generation of
circRNAs.
Our results demonstrate that circFOXP1 exerts a pivotal
role in MSCs on the support of their multipotent identity,
and that it is also involved in the regulation of MSC dif-
ferentiation. Indeed, circFOXP1 was consistently downreg-
ulated across all in vitro generated mesodermal derivatives
studied, compared to undifferentiatedMSCs. This was con-
firmed in human biopsies of bone, cartilage and adipose tis-
sue from healthy individuals.
Furthermore, our data show that solely circFOXP1,
but not FOXP1 mRNA, regulates MSC identity both in
vitro and following transplantation: circFOXP1 knock-
down rapidly reduced cell surface proteins of MSCs cor-
related with high colony formation and dramatically de-
creased MSC differentiation in culture. These results were
confirmed in vivo, where circFOXP1-KD MSCs lose their
ability to regenerate bone in a created non-union defect in
rats.
Defining the signaling network activated in adult stem
cells is an essential step toward understanding their capa-
bilities to differentiate and regenerate tissues. For instance,
MSCs express a set of transcripts for genes encoding signal-
ing receptors linked to stem cell survival and growth (AXL,
PDGFR and EGFR) and self-renewal (EGFR, EPHR and
FGFR) (72–74).
Consistent with the observed abundant and stable cyto-
plasmic localization of circFOXP1, we hypothesized and
confirmed that it acts as a ‘sponge’ for multiple miRNAs,
reinforcing the idea that a single circRNA may target si-
multaneously different miRNAs. Strikingly, bioinformatics
showed that the combined action of miR-17–3p and miR-
127–5p may regulate growth, survival and balance between
undifferentiated and differentiated MSCs, via, for instance,
EGFR and non-canonical Wnt signaling. Indeed, EGFR
and non-canonical Wnt signaling must be correctly acti-
vated in MSCs to maintain multipotency and confer ef-
fective regenerative capacity (13,75–79). A deeper analysis
of non-canonical and canonical Wnt pathways during re-
programming to pluripotency of MSCs or during the op-
posite process hinted at a role for circFOXP1 modulating
this interplay. In MSCs, elevated levels of circFOXP1 sus-
tain non-canonical and consequently inhibit canonicalWnt
pathway. In hiPSCs, the low abundance of circFOXP1 allow
for miR17-3p/miR127-5p-mediated suppression of non-
canonical Wnt pathway, reinforcing endogenous canonical
Wnt signaling (Figure 7C).
In summary our work describes, for the first time, the role
of a circRNA in the control of the developmental potential
of human adult and fetal MSCs. In our model, an abun-
dant circRNA derived from the FOXP1 gene was able to
preserve the MSC multipotent state by sponging multiple
miRNAs. This functional interaction is fundamental to in-
hibit miRNA activity and avoid interference of signaling
cascades associated with stemness and differentiation. Al-
though it is likely that other mechanisms contribute to this
biological control, our data describe a circRNA-centered
molecular circuit exerting a regulatory function in MSCs.
circFOXP1 should be regarded as an essential gatekeeper
of MSC identity.
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